Liquidia LQDA
NASDAQ LQDA
$71.05 -4.28 (-5.68%)
At close: Aug 20, 2026 · 4:00 PM EDT

Liquidia (LQDA) EBIT Margin (2020 - 2026)

Liquidia (LQDA) posted quarterly EBIT Margin of 46.29% for Q1 2026, up 118171.0% year-over-year from N/an in Q1 2025, and up 115.28% quarter-over-quarter from 21.5% in Q4 2025.

Liquidia (LQDA) EBIT Margin (2020 - 2026) Analysis & Trends

Liquidia's EBIT Margin history runs 7 years deep, the most recent figure standing at 46.29% for Q1 2026.

  • In Q1 2026, EBIT Margin rose 118171.0% year-over-year to 46.29%; the TTM figure through Mar 2026 stood at 15.81% (up 92021.0% YoY), while the FY2025 annual figure was 32.45%, up 83418.0% from the prior year.
  • EBIT Margin for Q1 2026 stood at 46.29%, up from 21.5% in the prior quarter.
  • The five-year high for EBIT Margin was 46.29% in Q1 2026, with the low at 1237.81% in Q4 2024.
  • The 5-year median for EBIT Margin is 414.43% (2022), against an average of 459.38%.
  • The sharpest annual moves came in 2024 and 2025: EBIT Margin sank 76360 bps in 2024, then jumped 125932 bps in 2025.
  • Liquidia's EBIT Margin stood at 121.21% in 2022, then plunged by 381 bps to 583.45% in 2023, then slumped by 112 bps to 1237.81% in 2024, then surged by 102 bps to 21.5% in 2025, then surged by 115 bps to 46.29% in 2026.
  • Business Quant data shows LQDA's EBIT Margin at 46.29% in Q1 2026, 21.5% in Q4 2025, and 3.25% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn -5.58%
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn 33.91%
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 16.51%
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 42.23%
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn 0.17%
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn 15.80%
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 18.13%
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 Liquidia 6.31 Bn 6.03 Bn 160.92 Mn 49.81%

Historic Data

Download Data
DateValue
Jun 30, 2026 49.81%
Mar 31, 2026 46.29%
Dec 31, 2025 21.50%
Sep 30, 2025 3.25%
Jun 30, 2025 -424.41%
Mar 31, 2025 -1,135.42%
Dec 31, 2024 -1,237.81%
Sep 30, 2024 -656.23%
Jun 30, 2024 -743.29%
Mar 31, 2024 -969.08%
Dec 31, 2023 -583.45%
Sep 30, 2023 -404.87%
Jun 30, 2023 -476.91%
Mar 31, 2023 -205.48%
Dec 31, 2022 -121.21%
Sep 30, 2022 -279.02%
Jun 30, 2022 -228.94%
Mar 31, 2022 -414.43%
Dec 31, 2021 -353.41%
Sep 30, 2021 -222.71%